Comparison Hemodynamic Effects of Midazolam and Dexmedetomidine as a Premedication in Patients Undergoing Upper Limb Surgeries: A Double-blind Intervention

Message:
Article Type:
Research/Original Article (دارای رتبه معتبر)
Abstract:
Introduction

Premedication is an integral part of general anesthesia which has side effects. The aim of this study was to compare the hemodynamic effects of Dexmedetomidine and Midazolam as a premedication in patients undergoing elective upper limb surgery during induction of anesthesia and postoperative shivering.

Methods

60 candidates for elective upper limb surgery who referred to Shahid Rajaee hospital were studied with the double-blind clinical trial method. Patients were randomly divided into two groups, included: 1. Midazolam and 2.Dexmedetomidine. SPO2, MAP, Heart rate, Systolic, and Diastolic blood pressure and postoperative shivering were evaluated at; early entrance time, before induction, 1, 5, 10 minutes after intubation, Post-extubating and recovery in all patients as well as post-surgery shivering. The collected data were analyzed using Chi-square, ANOVA and GLM Repeated Measure by using SPSS 19 software. The P < 0. 05 was considered as the significance level.

Results

At all times, the mean SPO2 was significantly higher in Dexmedetomidine than in the Midazolam group, which was significant at 10 minutes after intubation (P < 0.001). Mean MAP, Heart rate, Systolic and Diastolic blood pressure were significantly further in Midazolam group than Dexmedetomidine group at all times. Postoperative shivering in patients with Dexmedetomidine was significantly lower than the Midazolam group (P < 0.001).

Conclusions

The results showed that Dexmedetomidine has a better hemodynamic control during anesthesia. It also reduces the incidence of postoperative shivering.

Language:
Persian
Published:
Journal of North Khorasan University of Medical Sciences, Volume:11 Issue: 4, 2020
Pages:
45 to 51
magiran.com/p2108114  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!